Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ 126	$ (246)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	285	305
Deferred income taxes	(242)	2
Government and other legal settlements and related costs	4	9
Stock-based compensation expense	5	6
Impairment and loss on sale of businesses, net	56	71
Loss from early extinguishment of debt	4	31
Other non-cash expenses, net	73	101
Changes in operating assets and liabilities, net of effects of acquisitions and divestitures:
Patient accounts receivable	313	(7)
Supplies, prepaid expenses and other current assets	21	72
Medicare accelerated payments	1,158
Unrecognized pandemic relief funds	116
Accounts payable, accrued liabilities and income taxes	(160)	25
Other	(49)	(104)
Net cash provided by operating activities	1,710	265
Cash flows from investing activities:
Acquisitions of facilities and other related businesses		(13)
Purchases of property and equipment	(192)	(212)
Proceeds from disposition of hospitals and other ancillary operations	152	161
Proceeds from sale of property and equipment	2	1
Purchases of available-for-sale debt securities and equity securities	(39)	(39)
Proceeds from sales of available-for-sale debt securities and equity securities	43	52
Increase in other investments	(19)	(97)
Net cash used in investing activities	(53)	(147)
Cash flows from financing activities:
Repurchase of restricted stock shares for payroll tax withholding requirements	(1)	(1)
Deferred financing costs and other debt-related costs	(32)	(28)
Proceeds from noncontrolling investors in joint ventures		2
Redemption of noncontrolling investments in joint ventures	(2)	(2)
Distributions to noncontrolling investors in joint ventures	(57)	(57)
Proceeds from sale-lease back	2
Other borrowings	31	23
Issuance of long-term debt	1,462	2,034
Proceeds from ABL Facility	540	25
Repayments of long-term indebtedness	(2,264)	(2,103)
Net cash used in financing activities	(321)	(107)
Net change in cash and cash equivalents	1,336	11
Cash and cash equivalents at beginning of period	216	196
Cash and cash equivalents at end of period	1,552	207
Supplemental disclosure of cash flow information:
Interest payments	(486)	(318)
Income tax refunds (payments), net	$ 2	$ 3